Bringing speed, accuracy, and precision to the fight against COVID-19
This Sherlock Biosciences kit is based on the SHERLOCK method, which stands for Specific High-sensitivity Enzymatic Reporter unLOCKing. The kit works by programming a CRISPR nuclease to detect the presence of a specific genetic signature—in this case, the genetic signature for SARS-CoV-2—in a nasal swab, nasopharyngeal swab, oropharyngeal swab, or bronchoalveolar lavage (BAL) specimen. When the signature is found, the CRISPR enzyme is activated and releases a detectable signal. By enabling rapid identification, the Sherlock CRISPR SARS-CoV-2 kit will be a critical addition to the arsenal of rapid tools being used to detect COVID-19.
The Sherlock CRISPR SARS-CoV-2 in vitro diagnostic kit provides:
We know that increased testing capacity is vital. We are working hard to prioritize inquiries from physicians, laboratory experts and researchers worldwide to enable them to assist frontline workers leading the charge against this pandemic. Please complete this short form, and we’ll be in touch to discuss your needs ASAP.